 | • レポートコード：MRC2-11QY11684 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は破壊的行動障害（DBD）のグローバル市場について調査・分析したレポートです。種類別（行為障害（CD）、反抗挑戦性障害（ODD））市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別破壊的行動障害（DBD）の競争状況、市場シェア ・世界の破壊的行動障害（DBD）市場：種類別市場規模 2015年-2020年（行為障害（CD）、反抗挑戦性障害（ODD）） ・世界の破壊的行動障害（DBD）市場：種類別市場規模予測 2021年-2026年（行為障害（CD）、反抗挑戦性障害（ODD）） ・世界の破壊的行動障害（DBD）市場：用途別市場規模 2015年-2020年（病院・クリニック、その他） ・世界の破壊的行動障害（DBD）市場：用途別市場規模予測 2021年-2026年（病院・クリニック、その他） ・北米の破壊的行動障害（DBD）市場分析：米国、カナダ ・ヨーロッパの破壊的行動障害（DBD）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの破壊的行動障害（DBD）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の破壊的行動障害（DBD）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの破壊的行動障害（DBD）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eli Lilly、Bionomics、Chelsea Therapeutics、Pfizer、Johnson & Johnson、DURECT、Novartis、McNeil Pharmaceuticals、Sunovion Pharmaceuticals、New River Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Disruptive Behavior Disorders (DBD) is behavioral disorders characterized by hostile and defiant behaviors that children and adolescents direct towards others.
The global disruptive behavior disorders market is being driven by the rise in the number of comorbid disorders, active involvement of NGO and government programs to increase awareness.
Market Analysis and Insights: Global Disruptive Behavior Disorders (DBD) Market
The global Disruptive Behavior Disorders (DBD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Disruptive Behavior Disorders (DBD) Scope and Market Size
Disruptive Behavior Disorders (DBD) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Disruptive Behavior Disorders (DBD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Eli Lilly
Bionomics
Chelsea Therapeutics
Pfizer
Johnson & Johnson
DURECT
Novartis
McNeil Pharmaceuticals
Sunovion Pharmaceuticals
New River Pharmaceuticals
Market segment by Type, the product can be split into
Conduct Disorder (CD)
Oppositional Defiant Disorder (ODD)
Market segment by Application, split into
Hospitals and Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Disruptive Behavior Disorders (DBD) Revenue
1.4 Market by Type
1.4.1 Global Disruptive Behavior Disorders (DBD) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Conduct Disorder (CD)
1.4.3 Oppositional Defiant Disorder (ODD)
1.5 Market by Application
1.5.1 Global Disruptive Behavior Disorders (DBD) Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Disruptive Behavior Disorders (DBD) Market Perspective (2015-2026)
2.2 Global Disruptive Behavior Disorders (DBD) Growth Trends by Regions
2.2.1 Disruptive Behavior Disorders (DBD) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Disruptive Behavior Disorders (DBD) Historic Market Share by Regions (2015-2020)
2.2.3 Disruptive Behavior Disorders (DBD) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Disruptive Behavior Disorders (DBD) Market Growth Strategy
2.3.6 Primary Interviews with Key Disruptive Behavior Disorders (DBD) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Disruptive Behavior Disorders (DBD) Players by Market Size
3.1.1 Global Top Disruptive Behavior Disorders (DBD) Players by Revenue (2015-2020)
3.1.2 Global Disruptive Behavior Disorders (DBD) Revenue Market Share by Players (2015-2020)
3.1.3 Global Disruptive Behavior Disorders (DBD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Disruptive Behavior Disorders (DBD) Market Concentration Ratio
3.2.1 Global Disruptive Behavior Disorders (DBD) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Disruptive Behavior Disorders (DBD) Revenue in 2019
3.3 Disruptive Behavior Disorders (DBD) Key Players Head office and Area Served
3.4 Key Players Disruptive Behavior Disorders (DBD) Product Solution and Service
3.5 Date of Enter into Disruptive Behavior Disorders (DBD) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Disruptive Behavior Disorders (DBD) Historic Market Size by Type (2015-2020)
4.2 Global Disruptive Behavior Disorders (DBD) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Disruptive Behavior Disorders (DBD) Market Size by Application (2015-2020)
5.2 Global Disruptive Behavior Disorders (DBD) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Disruptive Behavior Disorders (DBD) Market Size (2015-2020)
6.2 Disruptive Behavior Disorders (DBD) Key Players in North America (2019-2020)
6.3 North America Disruptive Behavior Disorders (DBD) Market Size by Type (2015-2020)
6.4 North America Disruptive Behavior Disorders (DBD) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Disruptive Behavior Disorders (DBD) Market Size (2015-2020)
7.2 Disruptive Behavior Disorders (DBD) Key Players in Europe (2019-2020)
7.3 Europe Disruptive Behavior Disorders (DBD) Market Size by Type (2015-2020)
7.4 Europe Disruptive Behavior Disorders (DBD) Market Size by Application (2015-2020)
8 China
8.1 China Disruptive Behavior Disorders (DBD) Market Size (2015-2020)
8.2 Disruptive Behavior Disorders (DBD) Key Players in China (2019-2020)
8.3 China Disruptive Behavior Disorders (DBD) Market Size by Type (2015-2020)
8.4 China Disruptive Behavior Disorders (DBD) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Disruptive Behavior Disorders (DBD) Market Size (2015-2020)
9.2 Disruptive Behavior Disorders (DBD) Key Players in Japan (2019-2020)
9.3 Japan Disruptive Behavior Disorders (DBD) Market Size by Type (2015-2020)
9.4 Japan Disruptive Behavior Disorders (DBD) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Disruptive Behavior Disorders (DBD) Market Size (2015-2020)
10.2 Disruptive Behavior Disorders (DBD) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Disruptive Behavior Disorders (DBD) Market Size by Type (2015-2020)
10.4 Southeast Asia Disruptive Behavior Disorders (DBD) Market Size by Application (2015-2020)
11 India
11.1 India Disruptive Behavior Disorders (DBD) Market Size (2015-2020)
11.2 Disruptive Behavior Disorders (DBD) Key Players in India (2019-2020)
11.3 India Disruptive Behavior Disorders (DBD) Market Size by Type (2015-2020)
11.4 India Disruptive Behavior Disorders (DBD) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Disruptive Behavior Disorders (DBD) Market Size (2015-2020)
12.2 Disruptive Behavior Disorders (DBD) Key Players in Central & South America (2019-2020)
12.3 Central & South America Disruptive Behavior Disorders (DBD) Market Size by Type (2015-2020)
12.4 Central & South America Disruptive Behavior Disorders (DBD) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Eli Lilly
13.1.1 Eli Lilly Company Details
13.1.2 Eli Lilly Business Overview
13.1.3 Eli Lilly Disruptive Behavior Disorders (DBD) Introduction
13.1.4 Eli Lilly Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020))
13.1.5 Eli Lilly Recent Development
13.2 Bionomics
13.2.1 Bionomics Company Details
13.2.2 Bionomics Business Overview
13.2.3 Bionomics Disruptive Behavior Disorders (DBD) Introduction
13.2.4 Bionomics Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020)
13.2.5 Bionomics Recent Development
13.3 Chelsea Therapeutics
13.3.1 Chelsea Therapeutics Company Details
13.3.2 Chelsea Therapeutics Business Overview
13.3.3 Chelsea Therapeutics Disruptive Behavior Disorders (DBD) Introduction
13.3.4 Chelsea Therapeutics Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020)
13.3.5 Chelsea Therapeutics Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Disruptive Behavior Disorders (DBD) Introduction
13.4.4 Pfizer Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Details
13.5.2 Johnson & Johnson Business Overview
13.5.3 Johnson & Johnson Disruptive Behavior Disorders (DBD) Introduction
13.5.4 Johnson & Johnson Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020)
13.5.5 Johnson & Johnson Recent Development
13.6 DURECT
13.6.1 DURECT Company Details
13.6.2 DURECT Business Overview
13.6.3 DURECT Disruptive Behavior Disorders (DBD) Introduction
13.6.4 DURECT Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020)
13.6.5 DURECT Recent Development
13.7 Novartis
13.7.1 Novartis Company Details
13.7.2 Novartis Business Overview
13.7.3 Novartis Disruptive Behavior Disorders (DBD) Introduction
13.7.4 Novartis Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020)
13.7.5 Novartis Recent Development
13.8 McNeil Pharmaceuticals
13.8.1 McNeil Pharmaceuticals Company Details
13.8.2 McNeil Pharmaceuticals Business Overview
13.8.3 McNeil Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
13.8.4 McNeil Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020)
13.8.5 McNeil Pharmaceuticals Recent Development
13.9 Sunovion Pharmaceuticals
13.9.1 Sunovion Pharmaceuticals Company Details
13.9.2 Sunovion Pharmaceuticals Business Overview
13.9.3 Sunovion Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
13.9.4 Sunovion Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020)
13.9.5 Sunovion Pharmaceuticals Recent Development
13.10 New River Pharmaceuticals
13.10.1 New River Pharmaceuticals Company Details
13.10.2 New River Pharmaceuticals Business Overview
13.10.3 New River Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
13.10.4 New River Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020)
13.10.5 New River Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Disruptive Behavior Disorders (DBD) Key Market Segments
Table 2. Key Players Covered: Ranking by Disruptive Behavior Disorders (DBD) Revenue
Table 3. Ranking of Global Top Disruptive Behavior Disorders (DBD) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Disruptive Behavior Disorders (DBD) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Conduct Disorder (CD)
Table 6. Key Players of Oppositional Defiant Disorder (ODD)
Table 7. Global Disruptive Behavior Disorders (DBD) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Disruptive Behavior Disorders (DBD) Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Disruptive Behavior Disorders (DBD) Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Disruptive Behavior Disorders (DBD) Market Share by Regions (2015-2020)
Table 11. Global Disruptive Behavior Disorders (DBD) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Disruptive Behavior Disorders (DBD) Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Disruptive Behavior Disorders (DBD) Market Growth Strategy
Table 17. Main Points Interviewed from Key Disruptive Behavior Disorders (DBD) Players
Table 18. Global Disruptive Behavior Disorders (DBD) Revenue by Players (2015-2020) (Million US$)
Table 19. Global Disruptive Behavior Disorders (DBD) Market Share by Players (2015-2020)
Table 20. Global Top Disruptive Behavior Disorders (DBD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Disruptive Behavior Disorders (DBD) as of 2019)
Table 21. Global Disruptive Behavior Disorders (DBD) by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Disruptive Behavior Disorders (DBD) Product Solution and Service
Table 24. Date of Enter into Disruptive Behavior Disorders (DBD) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Disruptive Behavior Disorders (DBD) Market Size by Type (2015-2020) (Million US$)
Table 27. Global Disruptive Behavior Disorders (DBD) Market Size Share by Type (2015-2020)
Table 28. Global Disruptive Behavior Disorders (DBD) Revenue Market Share by Type (2021-2026)
Table 29. Global Disruptive Behavior Disorders (DBD) Market Size Share by Application (2015-2020)
Table 30. Global Disruptive Behavior Disorders (DBD) Market Size by Application (2015-2020) (Million US$)
Table 31. Global Disruptive Behavior Disorders (DBD) Market Size Share by Application (2021-2026)
Table 32. North America Key Players Disruptive Behavior Disorders (DBD) Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Disruptive Behavior Disorders (DBD) Market Share (2019-2020)
Table 34. North America Disruptive Behavior Disorders (DBD) Market Size by Type (2015-2020) (Million US$)
Table 35. North America Disruptive Behavior Disorders (DBD) Market Share by Type (2015-2020)
Table 36. North America Disruptive Behavior Disorders (DBD) Market Size by Application (2015-2020) (Million US$)
Table 37. North America Disruptive Behavior Disorders (DBD) Market Share by Application (2015-2020)
Table 38. Europe Key Players Disruptive Behavior Disorders (DBD) Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Disruptive Behavior Disorders (DBD) Market Share (2019-2020)
Table 40. Europe Disruptive Behavior Disorders (DBD) Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Disruptive Behavior Disorders (DBD) Market Share by Type (2015-2020)
Table 42. Europe Disruptive Behavior Disorders (DBD) Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Disruptive Behavior Disorders (DBD) Market Share by Application (2015-2020)
Table 44. China Key Players Disruptive Behavior Disorders (DBD) Revenue (2019-2020) (Million US$)
Table 45. China Key Players Disruptive Behavior Disorders (DBD) Market Share (2019-2020)
Table 46. China Disruptive Behavior Disorders (DBD) Market Size by Type (2015-2020) (Million US$)
Table 47. China Disruptive Behavior Disorders (DBD) Market Share by Type (2015-2020)
Table 48. China Disruptive Behavior Disorders (DBD) Market Size by Application (2015-2020) (Million US$)
Table 49. China Disruptive Behavior Disorders (DBD) Market Share by Application (2015-2020)
Table 50. Japan Key Players Disruptive Behavior Disorders (DBD) Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Disruptive Behavior Disorders (DBD) Market Share (2019-2020)
Table 52. Japan Disruptive Behavior Disorders (DBD) Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Disruptive Behavior Disorders (DBD) Market Share by Type (2015-2020)
Table 54. Japan Disruptive Behavior Disorders (DBD) Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Disruptive Behavior Disorders (DBD) Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Disruptive Behavior Disorders (DBD) Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Disruptive Behavior Disorders (DBD) Market Share (2019-2020)
Table 58. Southeast Asia Disruptive Behavior Disorders (DBD) Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Disruptive Behavior Disorders (DBD) Market Share by Type (2015-2020)
Table 60. Southeast Asia Disruptive Behavior Disorders (DBD) Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Disruptive Behavior Disorders (DBD) Market Share by Application (2015-2020)
Table 62. India Key Players Disruptive Behavior Disorders (DBD) Revenue (2019-2020) (Million US$)
Table 63. India Key Players Disruptive Behavior Disorders (DBD) Market Share (2019-2020)
Table 64. India Disruptive Behavior Disorders (DBD) Market Size by Type (2015-2020) (Million US$)
Table 65. India Disruptive Behavior Disorders (DBD) Market Share by Type (2015-2020)
Table 66. India Disruptive Behavior Disorders (DBD) Market Size by Application (2015-2020) (Million US$)
Table 67. India Disruptive Behavior Disorders (DBD) Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Disruptive Behavior Disorders (DBD) Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Disruptive Behavior Disorders (DBD) Market Share (2019-2020)
Table 70. Central & South America Disruptive Behavior Disorders (DBD) Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Disruptive Behavior Disorders (DBD) Market Share by Type (2015-2020)
Table 72. Central & South America Disruptive Behavior Disorders (DBD) Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Disruptive Behavior Disorders (DBD) Market Share by Application (2015-2020)
Table 74. Eli Lilly Company Details
Table 75. Eli Lilly Business Overview
Table 76. Eli Lilly Product
Table 77. Eli Lilly Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020) (Million US$)
Table 78. Eli Lilly Recent Development
Table 79. Bionomics Company Details
Table 80. Bionomics Business Overview
Table 81. Bionomics Product
Table 82. Bionomics Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020) (Million US$)
Table 83. Bionomics Recent Development
Table 84. Chelsea Therapeutics Company Details
Table 85. Chelsea Therapeutics Business Overview
Table 86. Chelsea Therapeutics Product
Table 87. Chelsea Therapeutics Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020) (Million US$)
Table 88. Chelsea Therapeutics Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Product
Table 92. Pfizer Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020) (Million US$)
Table 93. Pfizer Recent Development
Table 94. Johnson & Johnson Company Details
Table 95. Johnson & Johnson Business Overview
Table 96. Johnson & Johnson Product
Table 97. Johnson & Johnson Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020) (Million US$)
Table 98. Johnson & Johnson Recent Development
Table 99. DURECT Company Details
Table 100. DURECT Business Overview
Table 101. DURECT Product
Table 102. DURECT Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020) (Million US$)
Table 103. DURECT Recent Development
Table 104. Novartis Company Details
Table 105. Novartis Business Overview
Table 106. Novartis Product
Table 107. Novartis Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020) (Million US$)
Table 108. Novartis Recent Development
Table 109. McNeil Pharmaceuticals Business Overview
Table 110. McNeil Pharmaceuticals Product
Table 111. McNeil Pharmaceuticals Company Details
Table 112. McNeil Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020) (Million US$)
Table 113. McNeil Pharmaceuticals Recent Development
Table 114. Sunovion Pharmaceuticals Company Details
Table 115. Sunovion Pharmaceuticals Business Overview
Table 116. Sunovion Pharmaceuticals Product
Table 117. Sunovion Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020) (Million US$)
Table 118. Sunovion Pharmaceuticals Recent Development
Table 119. New River Pharmaceuticals Company Details
Table 120. New River Pharmaceuticals Business Overview
Table 121. New River Pharmaceuticals Product
Table 122. New River Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2015-2020) (Million US$)
Table 123. New River Pharmaceuticals Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Disruptive Behavior Disorders (DBD) Market Share by Type: 2020 VS 2026
Figure 2. Conduct Disorder (CD) Features
Figure 3. Oppositional Defiant Disorder (ODD) Features
Figure 4. Global Disruptive Behavior Disorders (DBD) Market Share by Application: 2020 VS 2026
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Others Case Studies
Figure 7. Disruptive Behavior Disorders (DBD) Report Years Considered
Figure 8. Global Disruptive Behavior Disorders (DBD) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Disruptive Behavior Disorders (DBD) Market Share by Regions: 2020 VS 2026
Figure 10. Global Disruptive Behavior Disorders (DBD) Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Disruptive Behavior Disorders (DBD) Market Share by Players in 2019
Figure 13. Global Top Disruptive Behavior Disorders (DBD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Disruptive Behavior Disorders (DBD) as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Disruptive Behavior Disorders (DBD) Revenue in 2019
Figure 15. North America Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Disruptive Behavior Disorders (DBD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
自閉症スペクトラム障害（ASD）治療の世界市場（～2026年） Autism spectrum disorder (ASD) refers to a group of complex neurodevelopment disorders characterized by repetitive and characteristic patterns of behavior and difficulties with social communication and interaction. According to CDC statistics, 1 in every 68 children suffers with autism. Innovative d…- 神経精神障害・治療の世界市場（～2026年） Neuropsychiatric disorder is a blanket medical term that encompasses a broad range of medical conditions that involve both neurology and psychiatry. Common neuropsychiatric disorders include seizures, attention deficits, cognitive deficits, palsies, uncontrolled anger, migraine headaches, addictions…
- 副甲状腺障害の世界市場（～2026年） Parathyroid disorders lead to abnormal levels of calcium in the blood that can cause brittle bones, kidney stones, fatigue, weakness, and other problems. Patients with chronic kidney disease may develop secondary hyperparathyroidism with resultant chronic kidney disease-mineral and bone disorder. Hy…
- パニック障害の世界市場（～2026年） Panic disorder is an anxiety disorder characterized by reoccurring unexpected panic attacks. Panic disorder is usually treated with counselling and medications. The type of counselling used is typically cognitive behavioral therapy which is effective in more than half of people. Medications used inc…
- 単遺伝性疾患検査の世界市場（～2026年） According to Mendel's Laws, the monogenetic disorders are inherited because of a single defective gene on the autosomes. The monogenic disorders are caused by single mutated gene which can be present on single or both chromosomes. Females and males are equally affected by this disorder due to the co…